Novartis investigational novel STAMP inhibitor asciminib (ABL001) meets primary endpoint of Phase III chronic myeloid leukemia study

    NEXT STORY
    Saniona förstärker ledningsgruppen genom utnämningar av Chief Financial Officer, Chief Communications Officer och Chief Human Resources Officer
    PREV STORY
    Global Multiplexed Diagnostics Market Is Expected to Reach USD 38.30 Billion by 2027 : Fior Markets
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Global Dry Eye Syndrome Market to Exhibit a CAGR of 4.7% and Hit USD 6.54 Billion by 2027; Growing Awareness about Eye Disorders to Incite Business Development, states Fortune Business Insights™

    author_avatar
    NASDAQ Market News

    Global Corporate Wellness Industry

    author_avatar
    NASDAQ Market News

    The global nephrology devices market accounted for $12,012 XX million in 2018, and is expected to reach $16,421 XX million by 2026, registering a CAGR of XX4.0% from 2019 to 2026

    author_avatar
    NASDAQ Market News